Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Unknown 5Recruiting 4Not yet recruiting 3Active not recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Radiotherapy 2Lenalidomide 2Carboplatin 2tislelizumab 1irinotecan sucrosofate 1enzalutamide 1Ruthenium-106 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Melphalan 1Mannitol 1Leukocyte Count 1Folfox protocol 1Dexamethasone 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Enrolling by invitation × Folfox protocol × Clear all
NCT06936527 2025-09-03

XS-03-II201

NovaOnco Therapeutics Co., Ltd.

Phase 1/2 Enrolling by invitation
102 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡